Free Trial

Nutrien (NTR) Stock Forecast & Price Target

Nutrien logo
$53.12 +0.67 (+1.28%)
Closing price 02/20/2025 03:59 PM Eastern
Extended Trading
$53.24 +0.13 (+0.24%)
As of 02/20/2025 07:02 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Nutrien - Analysts' Recommendations and Stock Price Forecast (2025)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Sell
1
Hold
6
Buy
10

Based on 17 Wall Street analysts who have issued ratings for Nutrien in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 17 analysts, 1 has given a sell rating, 6 have given a hold rating, and 10 have given a buy rating for NTR.

Consensus Price Target

$59.22
11.49% Upside
According to the 17 analysts' twelve-month price targets for Nutrien, the average price target is $59.22. The highest price target for NTR is $75.00, while the lowest price target for NTR is $50.00. The average price target represents a forecasted upside of 11.49% from the current price of $53.12.
Get the Latest News and Ratings for NTR and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Nutrien and its competitors.

Sign Up

NTR Analyst Ratings Over Time

TypeCurrent Forecast
2/22/24 to 2/21/25
1 Month Ago
1/23/24 to 1/22/25
3 Months Ago
11/24/23 to 11/23/24
1 Year Ago
2/22/23 to 2/22/24
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
10 Buy rating(s)
10 Buy rating(s)
10 Buy rating(s)
10 Buy rating(s)
Hold
6 Hold rating(s)
6 Hold rating(s)
6 Hold rating(s)
9 Hold rating(s)
Sell
1 Sell rating(s)
1 Sell rating(s)
3 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$59.22$58.39$60.33$73.21
Forecasted Upside11.49% Upside10.98% Upside28.56% Upside35.20% Upside
Consensus Rating
Moderate Buy
Moderate Buy
Hold
Moderate Buy

NTR Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

NTR Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Nutrien Stock vs. The Competition

TypeNutrienBasic Materials CompaniesS&P 500
Consensus Rating Score
2.53
2.75
2.53
Consensus RatingModerate BuyModerate BuyModerate Buy
Predicted Upside11.49% Upside144.53% Upside12.82% Upside
News Sentiment Rating
Positive News

See Recent NTR News
Positive News
Positive News
DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
2/20/2025Mizuho
2 of 5 stars
Christopher Parkinson
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost TargetNeutral ➝ Neutral$52.00 ➝ $55.00+3.55%
2/20/2025UBS Group
4 of 5 stars
J. Spector
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost TargetNeutral ➝ Neutral$53.00 ➝ $54.00+0.30%
2/10/2025Scotiabank
5 of 5 stars
Ben Isaacson
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost TargetSector Outperform ➝ Sector Outperform$59.00 ➝ $60.00+17.87%
1/28/2025Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
R. Garchitorena
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost TargetEqual Weight ➝ Equal Weight$52.00 ➝ $53.00+0.83%
1/27/2025Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
C. Neivert
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost TargetOverweight ➝ Overweight$58.00 ➝ $63.00+18.27%
1/21/2025Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Benjamin Theurer
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Equal Weight$55.00 ➝ $56.00+8.56%
1/13/2025JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Jeffrey Zekauskas
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeUnderweight ➝ Neutral$40.00 ➝ $50.00+3.18%
12/12/2024Oppenheimer
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageOutperform$60.00+25.31%
12/10/2024CIBC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingOutperformer$60.00 ➝ $55.00+12.45%
12/3/2024Raymond James
Subscribe to MarketBeat All Access for the recommendation accuracy rating
S. Hansen
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeMarket Perform ➝ Outperform$58.00 ➝ $60.00+25.63%
11/12/2024TD Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetBuy$63.00 ➝ $61.00+29.32%
9/20/2024Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingOutperform ➝ Outperform$60.00 ➝ $60.00+25.26%
9/10/2024The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
A. Samuelson
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeBuy ➝ Neutral$69.00 ➝ $53.00+14.99%
8/9/2024BMO Capital Markets
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetOutperform ➝ Outperform$80.00 ➝ $75.00+63.58%
8/2/2024Hsbc Global Res
Subscribe to MarketBeat All Access for the recommendation accuracy rating
S. Seshadri
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeHold ➝ Moderate Sell
8/2/2024HSBC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeHold ➝ Reduce
4/29/2024Berenberg Bank
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeHold ➝ Buy$60.00 ➝ $66.00+25.59%
3/26/2024Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageBuy$62.00+17.92%
3/1/2024Wolfe Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageOutperform$66.00+26.36%
1/19/2024Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy ➝ Buy$72.00 ➝ $75.00+49.31%
11/30/2023BNP Paribas
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeOutperform ➝ Neutral
7/25/2023Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingEqual Weight ➝ Equal Weight$70.00+5.69%
6/8/2023Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower Target$94.00 ➝ $85.00+44.73%
5/11/2023Credit Suisse Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower Target$70.00 ➝ $60.00-5.30%
3/28/2023Erste Group Bank
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingBuy ➝ Hold

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Friday at 05:25 AM ET.


Should I Buy Nutrien Stock? NTR Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Tuesday, February 18, 2025. Please send any questions or comments about these Nutrien pros and cons to contact@marketbeat.com.

Nutrien
Bull Case

green Wall Street bull icon

Here are some ways that investors could benefit from investing in Nutrien Ltd.:

  • The stock has shown resilience with a current price around $50.00, which is within its fifty-two week range of $43.69 to $60.87, indicating potential for growth.
  • Analysts have a positive outlook, with an average rating of "Moderate Buy" and a price target of $59.00, suggesting that there is room for appreciation in the stock price.
  • Institutional ownership is strong at 63.10%, which often indicates confidence in the company's future performance and stability.
  • Recent upgrades from major brokerages, such as JPMorgan Chase raising its rating from "underweight" to "neutral," reflect improved sentiment towards the stock.
  • Nutrien Ltd. operates in the essential agricultural sector, providing crop inputs and services, which are critical for food production and can be less volatile during economic downturns.

Nutrien
Bear Case

red Wall Street bear icon

Investors should be bearish about investing in Nutrien Ltd. for these reasons:

  • Some analysts have downgraded their price targets, such as CIBC reducing its target from $60.00 to $55.00, indicating potential concerns about future performance.
  • The stock has experienced fluctuations, with a 50-day moving average of $48.91, which may suggest volatility and uncertainty in the short term.
  • One investment analyst has issued a sell rating, which could signal caution for potential investors regarding the stock's future trajectory.
  • Recent changes in institutional holdings, while generally positive, also indicate that some investors are reassessing their positions, which could lead to further volatility.
  • The agricultural sector can be heavily influenced by external factors such as weather conditions and commodity prices, which may pose risks to Nutrien Ltd.'s performance.

NTR Forecast - Frequently Asked Questions

According to the research reports of 17 Wall Street equities research analysts, the average twelve-month stock price forecast for Nutrien is $59.22, with a high forecast of $75.00 and a low forecast of $50.00.

17 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Nutrien in the last twelve months. There is currently 1 sell rating, 6 hold ratings and 10 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" NTR shares.

According to analysts, Nutrien's stock has a predicted upside of 11.49% based on their 12-month stock forecasts.

Over the previous 90 days, Nutrien's stock had 3 upgrades by analysts.

Nutrien has been rated by research analysts at Barclays, CIBC, JPMorgan Chase & Co., Mizuho, Oppenheimer, Piper Sandler, Raymond James, Scotiabank, UBS Group, and Wells Fargo & Company in the past 90 days.

Analysts like Nutrien less than other "basic materials" companies. The consensus rating score for Nutrien is 2.53 while the average consensus rating score for "basic materials" companies is 2.75. Learn more on how NTR compares to other companies.


This page (NYSE:NTR) was last updated on 2/21/2025 by MarketBeat.com Staff
From Our Partners